GlassScriptPhysician profile
Melissa Ranallo
NPI 1699950345
$5,412.14
in general payments reported to CMS, 2019-2025
39 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,557 · 2022: $1,332 · 2023: $1,001 · 2024: $885 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456 · Education: $66.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,456.39 |
| Education | $66.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $668.64 | 2021-2025 | |
| Novo Nordisk INC | $617.10 | 2021-2025 | Wegovy, Saxenda |
| Mayne Pharma Commercial LLC | $413.05 | 2021-2025 | |
| Pfizer INC. | $370.89 | 2021-2025 | |
| Avion Pharmaceuticals | $301.98 | 2021-2023 | Balcoltra |
| Evofem Biosciences, INC. | $267.55 | 2021-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $264.26 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $201.38 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $198.92 | 2023-2025 | Veozah |
| Millicent US INC | $175.79 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $170.30 | 2022-2024 | |
| Exact Sciences Corporation | $156.39 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $146.65 | 2021-2022 | |
| Therapeuticsmd, INC. | $143.90 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $138.98 | 2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Ranallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.